Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Jacquelyn L Sumer

General Counsel at Cullinan Therapeutics, Inc. (CGEM)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $137K

Reported trades

Filed Stock Type Shares Price Value Since
Feb 25SEC CGEMCullinan Therapeutics, Inc. Sell 3,601128,089 held (−3%) $14.47 $52K -10.6%
Feb 23SEC CGEMCullinan Therapeutics, Inc. Sell 3,742131,690 held (−3%) $13.62 $51K -5.1%
Dec 19SEC CGEMCullinan Therapeutics, Inc. Sell 3,480135,432 held (−3%) $9.67 $34K +33.7%